跳至主要内容
临床试验/NCT02597595
NCT02597595已完成不适用

Effects of Spirulina on Cardiac Functions in Children With Beta Thalassemia Major

Tanta University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
cardiac functions measured by echocardiography

研究概览

简要总结

The aim of this study is to evaluate the cardioprotective effect of spirulina in children with beta thalassemia.

详细描述

The aim of this study is to evaluate the cardioprotective effect of spirulina in children with beta thalassemia.

this study will be carried on thirty children with beta thalassemia major from those attending the Hematology Unit of Pediatric department at Tanta University Hospital, and another thirty healthy children of matched age and sex will be enrolled as controls.

all studied children will be subjected to careful history taking and through clinical examination. laboratory investigations will be done including complete blood count, hemoglobin electrophoresis, serum ferritin, liver and kidney functions, and troponin-1 plasma level. echocardiographic assessment of the cardiac functions will be done for all patients. Source data will be the patients medical records.

oral spirulina will be given for studied patients for 3 months, and clinical examination, laboratory investigations and cardiac functions will be assessed at the time of inclusion in the study, and again after 3 months of regular spirulina supplementation.

An informed consent will be obtained from parents of all included subjects. the results of this study will be tabulated and statistically analyzed using Statistical Package for the Social Sciences (SPSS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Care Provider)

入排标准

年龄范围
4 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • children suffering from beta thalassemia major with age range from 4-18 years

排除标准

  • children with congenital heart diseases children with rheumatic heart diseases presence of heart failure children with coronary arterial disease children with cardiomyopathy

结局指标

主要结局

cardiac functions measured by echocardiography

时间窗: after 3 months of regular oral spirulina supplementation

Fractional shortening \[FS\]. Mitral flow early phase filling velocity \[E\], peak atrial phase filling velocity\[A\] and E/A ratio, and left ventricular (LV) diastolic function

次要结局

  • cardiac functions measured by troponin-1 plasma level.(after 3 months of regular oral spirulina supplementation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor Mohamed Elshanshory

professor and head of hematology and oncology unit at pediatric department

Tanta University

研究点 (2)

Loading locations...

相似试验